日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Changes in mean corpuscular volume after erythropoiesis-stimulating agent treatment are associated with renal outcomes in non-dialysis-dependent chronic kidney disease

红细胞生成刺激剂治疗后平均红细胞体积的变化与非透析依赖性慢性肾脏病患者的肾脏预后相关。

Son, Raku; Fujimaru, Takuya; Kagimura, Tatsuo; Sofue, Tadashi; Masaki, Takao; Nakayama, Masaaki; Narita, Ichiei

Erythropoiesis-stimulating agent hyporesponsiveness and malignancy development in patients with non-dialysis chronic kidney disease: a prospective cohort study

非透析慢性肾脏病患者促红细胞生成素反应低下与恶性肿瘤发生的关系:一项前瞻性队列研究

Hashimoto, Nobuhiro; Hayashi, Terumasa; Kagimura, Tatsuo; Narita, Ichiei

Association of serum phosphate levels and statin use with cardiovascular events in Japanese patients on chronic haemodialysis: a post-hoc analysis of the LANDMARK trial

血清磷酸盐水平和使用他汀类药物与日本慢性血液透析患者心血管事件的相关性:LANDMARK试验的事后分析

Saito, Tomohiro; Mizobuchi, Masahide; Yamakawa, Akane; Kagimura, Tatsuo; Ogata, Hiroaki; Fukagawa, Masafumi; Hirakata, Hideki; Akizawa, Tadao; Honda, Hirokazu

Attribute based cross classification analyses from the BRIGHTEN study reveal that therapeutic responsiveness to erythropoiesis stimulating agents predicts cardiorenal prognosis in renal anemia

来自 BRIGHTEN 研究的基于属性的交叉分类分析表明,对促红细胞生成剂的治疗反应可预测肾性贫血患者的心肾预后

Kataoka, Hiroshi; Hayashi, Terumasa; Nangaku, Masaomi; Narita, Ichiei; Kagimura, Tatsuo; Nitta, Kosaku; Hoshino, Junichi

N-terminal pro-brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease

N端脑钠肽前体与慢性肾脏病贫血患者的心肾结局

Nishi, Hiroshi; Nangaku, Masaomi; Sofue, Tadashi; Kagimura, Tatsuo; Narita, Ichiei

Postmarketing Surveillance of Thrombectomy Using a Tron FX Stent Retriever for Large and Medium Vessel Occlusion

使用Tron FX支架取栓器治疗大中型血管闭塞的血栓切除术的上市后监测

Imamura, Hirotoshi; Sakai, Nobuyuki; Takeuchi, Masataka; Ohta, Tsuyoshi; Ohara, Nobuyuki; Yazawa, Yukako; Akiyama, Yoshinori; Fukuda, Maki; Imai, Keisuke; Sakai, Chiaki; Matsumoto, Yasushi; Matsumaru, Yuji; Yamagami, Hiroshi; Yoshimura, Shinichi; Ito, Yasushi; Kuwayama, Naoya; Kagimura, Tatsuo

Rapid increase in erythropoiesis-stimulating agent resistance is a risk factor for poor renal prognosis in patients with chronic kidney disease pre-dialysis: A BRIGHTEN study sub-analysis

红细胞生成刺激剂抵抗力的快速增加是慢性肾脏病透析前患者肾脏预后不良的危险因素:BRIGHTEN 研究的亚组分析

Kawamoto, Shinya; Masaki, Takao; Maruyama, Shoichi; Yamakawa, Akane; Kagimura, Tatsuo; Narita, Ichiei

Use of a cooling pack to reduce subcutaneous vaccine injection pain in children aged 3-6 years: A single-blind, randomized, parallel-group multicenter study

使用冷敷包减轻3-6岁儿童皮下疫苗注射疼痛:一项单盲、随机、平行组多中心研究

Okafuji, Ikuo; Washio, Ryuta; Okafuji, Takao; Tanaka, Yu; Kagimura, Tatsuo

Plasma monocyte chemoattractant protein-1 and the risk of kidney and cardiovascular outcomes in people with chronic kidney disease: results from the BRIGHTEN study

血浆单核细胞趋化蛋白-1与慢性肾脏病患者肾脏和心血管事件风险:BRIGHTEN 研究结果

Toyama, Tadashi; Kagimura, Tatsuo; Tanabe, Kenichiro; Iwata, Yasunori; Wada, Takashi; Narita, Ichiei

Mean Corpuscular Volume Is Not a Reliable Predictor of Iron Deficiency in Patients With Chronic Kidney Disease: A Post-Hoc Analysis of the BRIGHTEN Trial

平均红细胞体积并非慢性肾病患者缺铁的可靠预测指标:BRIGHTEN试验的事后分析

Shimizu, Sayaka; Kagimura, Tatsuo; Maruyama, Shoichi; Narita, Ichiei